(Q38322947)

2 September 2017

miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation (English)

1 reference

2 September 2017

1 reference

X Lin

1

1 reference

2 September 2017

K L Rice

2

1 reference

2 September 2017

M Buzzai

3

1 reference

2 September 2017

E Hexner

4

1 reference

2 September 2017

F F Costa

5

1 reference

2 September 2017

O Kilpivaara

6

1 reference

2 September 2017

A Mullally

7

1 reference

2 September 2017

M B Soares

8

1 reference

2 September 2017

B L Ebert

9

1 reference

2 September 2017

R Levine

10

1 reference

2 September 2017

J D Licht

11

1 reference

2 September 2017

6 August 2012

1 reference

2 September 2017

1 reference

2 September 2017

27

1 reference

2 September 2017

2

1 reference

2 September 2017

344-352

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2012.224

2 September 2017

0 references

cites work

Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

MicroRNAs: regulators of gene expression and cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

How microRNAs control cell division, differentiation and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

MicroRNA-cancer connection: the beginning of a new tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Aberrant expression of microRNA in polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-gamma-induced murine fibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

MicroRNA miR-125a controls hematopoietic stem cell number

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

MIR-23A microRNA cluster inhibits B-cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Karyotype-specific microRNA signature in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Down-regulated miR-9 and miR-433 in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

miR-433 overexpression attenuates the spindle assembly checkpoint response to paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Densely interconnected transcriptional circuits control cell states in human hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

The guanylate-binding proteins (GBPs): proinflammatory cytokine-induced members of the dynamin superfamily with unique GTPase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

MicroRNA expression profile in granulocytes from primary myelofibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Characterization and discovery of novel miRNAs and moRNAs in JAK2V617F-mutated SET2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

APPL1: role in adiponectin signaling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

inferred from DOI database lookup

7 January 2021

based on heuristic

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

inferred from DOI database lookup

7 January 2021

based on heuristic

Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.224

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2012.224

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference